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Background
HIV-associated KS is the most common reported malig-
nancy in sub-Saharan Africa, and appropriate therapy of
KS requires accurate diagnosis. In much of the region,
however, KS diagnosis is limited to clinical suspicion with-
out pathologic confirmation. Where pathology is available,
specific anti-KSHV stains are rarely available and overall
pathologic accuracy for KS has not been evaluated.
Methods
We introduced skin punch biopsy for KS at HIV/AIDS
care clinics in Uganda and Kenya within the East Africa
IeDEA Consortium. Clinicians suspecting KS could
obtain a biopsy same day without charge. After interpre-
tation by local African pathologists who only had access
to routine H&E staining, biopsies were read by dermato-
pathologists at UCSF who could, at their discretion, recut
and restain specimens or stain against latency-associated
nuclear antigen (LANA) of KSHV. The interpretation by
the U.S. dermatopathologists, who serve a large base of
HIV-infected patients, was considered the gold standard.
Results
Clinicians at 26 HIV/AIDS clinics in Uganda and Kenya
referred 739 patients with clinically suspected KS for skin
biopsy. Overall, 77% (95% CI: 74%–80%) of these clinically
suspected cases were determined pathologically to be KS
after U.S. review; 19% had another diagnosis and 4% were
indeterminate. There was no significant difference in the
percentage found to be KS between countries (p=0.20) or
over time (p=0.11). When KS was not found, a wide vari-
ety of other diagnoses, both clinically significant and insig-
nificant, were made by the U.S. dermatopathologists
(Table 1). Two different pathology services, one in Uganda
one in Kenya, submitted biopsies for review by U.S. der-
matopathologists. Overall concordance between African
and U.S. interpretations was 71% (95% CI: 68%–74%).
When the U.S. interpretation was considered gold stan-
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Table 1
Sample of pathologic diagnoses made by U.S. dermatopathologists when KS was not present
Scar (n=9) Post-inflammatory pigmentation (9) Psoriasis (8) Lymphoma (5)
Wart (5) Bacillary angiomatosis (4) Morphea (4) Sarcoidosis (2)
Polyarteritis nodosa (2) Pyogenic granuloma (2) Mycobacterial dermatitis (2) Lichen planus (2)
Dermatofibroma (2) Castleman’s Disease (1) Squamous cell carcinoma (1) Deep fungal infection (1)
Secondary syphilis (1) Erythema multiforme (1) Eccrine poroma (1) Xanthoma (1)
Amerson et al. Infectious Agents and Cancer 2012, 7(Suppl 1):P6
http://www.infectagentscancer.com/content/7/S1/P6
© 2012 Amerson et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.dard, sensitivity of the African pathologic interpretation
for KS was 72% and specificity 84%. Over time, sensitivity
increased at one African center (p=0.04) but decreased in
another (p<0.001); specificity increased at one center
(p=0.001) and was unchanged in another (p=0.68).
Conclusions
Amongst clinicians at HIV/AIDS clinics in East Africa,
clinical suspicion of KS alone is not optimally specific
for KS diagnosis. Clinical suspicion alone often either
misdiagnoses conditions which are less concerning than
KS or misses other serious conditions that require dif-
ferent therapy than KS. Assuming the U.S. interpretation
is the gold standard, pathologic determination of KS in
East Africa is specific but not optimally sensitive. The
findings urge for increased availability of skin punch
biopsies for KS diagnosis in Africa and augmentation of
pathology services.
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